-
. Keith Channon – a 5 year renewable award that underpins the work of the group. You will lead a programme of research in the molecular mechanisms of cardiovascular disease, that may include a range of
-
programme focused on deciphering the molecular architecture of the HLA antigen processing and editing machinery, and investigating how it shapes tumour-specific antigen presentation. Your project will focus
-
the UKRI through the Frontier Guarantee Programme to Dr Jani R Bolla. The work is to be conducted in his lab in the Department Biology, University of Oxford, South Parks Road, Oxford, OX1 3RB
-
close to completion of, a PhD/DPhil in molecular and cellular neuroscience, or equivalent • Knowledge of the cell and molecular biology mechanisms of Parkinson’s disease, or related neurodegenerative
-
therapies. This role offers a unique opportunity to investigate the mechanisms of therapeutic resistance in glioblastoma and contribute to the development of more effective treatment strategies. Our research